gmo - go or no go? - nordgen · 2011. 3. 14. · gmo - go or no go? perspectives for genetically...
TRANSCRIPT
GMO - go or no go?
Perspectives for genetically modified cereals in Europe
Workshop on pre-breeding, Helsinki, 17-18 February, 2011
By Rasmus L. Hjortshøj, Sejet Planteforædling, DK
Gen
etic
s/Se
ed
DNA-markers
”fast-track methods”
GMO-breeding
Conventional breeding
”Genomics”
High yield
Broad effective resistance
Quality
feedbreadmalt
Genetic ressources
Well adapted agronomic traits
Stability in cultivation
Trials
”Enviromental traits”?
Too
lbox
foodenergy
Collaboration
Marketing
Own ”outside”
breeders exemption
Variety-listing/
PVP protection
Biotech
Genebank
competitor
Cereal valuechain
VariationSelectionDH‐methodsDNA‐markersResistanceQuality
Environment related traits?Drug production?
New traits?
Breeding
Rep
rese
ntat
ive
Variety identity
DUS testVCU valueNameIP:Plant-Variety-Protection (PVP)Patents
Seed managementField inspectionGermination testEtc….Va
riety
listin
g/IP
-pro
tect
ion
Cer
tifie
d se
ed Concept-farmingContract-farmingBulkproduction
Qua
lity
man
agem
entl/
trac
ebili
ty
Primary consumption
Qua
lity
man
ágem
ent/t
race
bilit
y
ExportFodderMaltFlour
MeatDairyEggBeerBread
Seed dressing Chemical protection + fertilizer
Primary productionPurity/Seed certification
End-use
Qua
lity
man
agem
ent/t
race
bilit
y
The cost of developing a GM variety!
Kilde: ”Plantekongres 2010”
”Traits” for a successfull GMO?Input-traits-agronomy-resistance
Output-traits- end-use (protein & oil content, biofuel etc.
Monogenic(/”simple”)
Polygenic(/”advanced”)
Round-Up Ready®
BT- resistance
Water use efficiency (WUE)
Nitrogen fixation
Essential aminoacids
HCN10®
Secondary metabolites (drugs)
Flavr Savr®
”1’ generation” ”2. generation”
Amflora®
MIR604®MS8xRF3®
OXY-235® X17-2®
Delayed riping melons
Virus resistance
Colour- DianthusSenescence delay - Dianthus
High oleic acid
Drought resistant maize
”Traits” for a successfull GMO?Input-traits = cost/benefit directly on farmer-agronomy-resistance
Output-traits = cost/benefit on consumer AND farmer- end-use (protein & oil content, biofuel etc.
Monogenic(/”simple”)
Polygenic(/”advanced”)
Round-Up Ready®
BT- resistance
Water use efficiency (WUE)
Nitrogen fixation
Essential aminoacids
MIR604®
Secondary metabolites (drugs)
Flavr Savr®
Niche markets
Global market
Amflora®
HCN10®
MS8xRF3®
X17-2®OXY-235®
Delayed riping melons
ZW20®
Senescence delay - DianthusColour- Dianthus
Drought resistant maize
3 cornerstones in the GM debate
• In order for GM‐cereals to be of optimum benefit for as well society, as farmers and breeders (at least) 3 issues have to be considered:
‐ Biology; relevant, manageable, add value.
‐ Regulation; presence of GM in seed, co‐existence with organic farming etc.
‐ IP; patent versus PVP, utility etc…
Regulation• Co‐existence with organic farming?• Zero‐tolerance for GM in seed.• Zero tolerance for (EU) non‐authorized GM in fodder.• Labelling.• COMPAC solution. Will it make insurance impossible for
small/medium companies = monopolizing GM technique?
IP• Breeders exemption not part of patent law.
• ex. 2 patented GM traits in variety makes ¾ of a cross unusable for conventional breeding.
• How to ensure return of investment?
Conclusion
• GM increases chance of solving drought, salinity, climate change etc.
• So far no evidence of GM being dangerous to humans.
• GM increases market areas for cereals.
• GM’s offer possiblity to protect investment.
= GM will be part of the future.
= But GM is not the only, nor necessarily the best, solution!
http://californiaagriculture.ucanr.org
BSPB maj 2010
GM- breeding: resistance towards cornborerConventional/biotech breeding; resistance against Orange Midge
GM-breeding; increased phytase activity in the wheat kernel
Remember ‐ the GM‐debate will not disappear!
Thank you for your attention!Rasmus L. Hjortshøj